Alfonso Luca Pendolino, Anika Kaura, Annakan V Navaratnam, Monica Pendolino, Gerolamo Bianchi, Samit Unadkat, Giancarlo Ottaviano, Premjit S Randhawa, Peter J Andrews
{"title":"抗中性粒细胞细胞质抗体相关血管增生的嗅觉功能障碍:文献综述。","authors":"Alfonso Luca Pendolino, Anika Kaura, Annakan V Navaratnam, Monica Pendolino, Gerolamo Bianchi, Samit Unadkat, Giancarlo Ottaviano, Premjit S Randhawa, Peter J Andrews","doi":"10.5662/wjm.v11.i2.15","DOIUrl":null,"url":null,"abstract":"<p><p>Olfactory dysfunction (OD) has been described in patients with antineutrophil cytoplasmic antibody-associated vasculitides (AAV), but the underlying mechanisms are not completely understood. The causes of altered smell function can generally be divided into conductive, sensorineural or others. To date no specific treatment is available for AAV-related OD and the efficacy of currently available options has not been explored. The aim of this review is to provide an overview of the causes that may lead to OD in patients with AAV. Current available treatments for OD and possible options in patients with AAV presenting with smell impairment are also mentioned.</p>","PeriodicalId":23729,"journal":{"name":"World journal of methodology","volume":"11 2","pages":"15-22"},"PeriodicalIF":0.0000,"publicationDate":"2021-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c1/63/WJM-11-15.PMC7970017.pdf","citationCount":"1","resultStr":"{\"title\":\"Olfactory dysfunction in antineutrophil cytoplasmic antibody-associated vasculitides: A review of the literature.\",\"authors\":\"Alfonso Luca Pendolino, Anika Kaura, Annakan V Navaratnam, Monica Pendolino, Gerolamo Bianchi, Samit Unadkat, Giancarlo Ottaviano, Premjit S Randhawa, Peter J Andrews\",\"doi\":\"10.5662/wjm.v11.i2.15\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Olfactory dysfunction (OD) has been described in patients with antineutrophil cytoplasmic antibody-associated vasculitides (AAV), but the underlying mechanisms are not completely understood. The causes of altered smell function can generally be divided into conductive, sensorineural or others. To date no specific treatment is available for AAV-related OD and the efficacy of currently available options has not been explored. The aim of this review is to provide an overview of the causes that may lead to OD in patients with AAV. Current available treatments for OD and possible options in patients with AAV presenting with smell impairment are also mentioned.</p>\",\"PeriodicalId\":23729,\"journal\":{\"name\":\"World journal of methodology\",\"volume\":\"11 2\",\"pages\":\"15-22\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-03-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c1/63/WJM-11-15.PMC7970017.pdf\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"World journal of methodology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5662/wjm.v11.i2.15\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"World journal of methodology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5662/wjm.v11.i2.15","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Olfactory dysfunction in antineutrophil cytoplasmic antibody-associated vasculitides: A review of the literature.
Olfactory dysfunction (OD) has been described in patients with antineutrophil cytoplasmic antibody-associated vasculitides (AAV), but the underlying mechanisms are not completely understood. The causes of altered smell function can generally be divided into conductive, sensorineural or others. To date no specific treatment is available for AAV-related OD and the efficacy of currently available options has not been explored. The aim of this review is to provide an overview of the causes that may lead to OD in patients with AAV. Current available treatments for OD and possible options in patients with AAV presenting with smell impairment are also mentioned.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
